TransMedics Reports Second Quarter 2024 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to TransMedics Reports Second Quarter 2024 Financial Results

TransMedics Group (TMDX) PT Raised to $200 at Oppenheimer

August 1, 2024 6:04 AM EDT

Oppenheimer analyst Suraj Kalia raised the price target on TransMedics Group (NASDAQ: TMDX) to $200.00 (from $125.00) while maintaining a Outperform rating.

The analyst comments "TransMedics reported 2Q24 revs. of $114.3M, blowing past our/consensus $100.2M/$98.8M estimates. In Q2, ~126 (+21 seq.; ~55 liver, ~57 heart, ~14 lung) transplant... More